MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
Clinical trial NCT04074564 · UNKNOWN
Trial details
- NCT number
- NCT04074564
- Sponsor
- HRYZ Biotech Co.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-22
- Primary completion
- 2024-08-07
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.